
Opinion|Videos|April 7, 2025
Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment Strategies
Experts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What have been your care strategies for brain metastasis that are beneficial for the patients and their families.
Advertisement
Related to this article

Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.

The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.

FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.

Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.

The FDA has approved oral iberdomide (Zenbexus) for relapsed/refractory multiple myeloma, offering patients a highly potent, accessible therapy.

Oncology clinicians must actively champion NCCN guidelines as a critical pillar of breast cancer survivorship care,

With daraxonrasib approved for metastatic pancreatic cancer, Yolanda Justal, APRN, discusses essential nursing workflows for home-based care.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Psycho-Oncology Care: Dr. Erik Bengtsen on Psilocybin & Patient Distress
2
Palliative and Psycho-Oncology Care: Dr. Ramy Sedhom on Patient Distress Signs
3
FDA Approves Lutetium Lu 177 Dotatate for GEP-NET Care
4
Nurse-Led Support Reduces Death Anxiety in Breast Cancer Care
5



